贝伐单抗对卵巢癌细胞减灭术后八个月阴道残端脏器脱出的影响：一例报告
Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report.
作者信息
Skwara Amanda J, Schilder Russell J, Zibelli Allison, Rosenblum Norman G
机构信息
Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
Department of Medical Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA ; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
出版信息
Gynecol Oncol Case Rep. 2013 Jul 1;6:7-9. doi: 10.1016/j.gynor.2013.06.005. eCollection 2013.
•44 year old woman treated with bevacizumab for metastatic epithelial ovarian cancer•The patient experienced vaginal cuff dehiscence and evisceration at 8 months post-operatively.•Metastasis at the surgical site and chronic inflammation implicated.
•44岁女性，接受贝伐单抗治疗转移性上皮性卵巢癌
•患者术后8个月出现阴道残端裂开和脏器脱出。
•考虑手术部位转移和慢性炎症。
Zotero 插件